Filter Results :

Your search for T-Cell returned 30 reports

Sort by


Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary Cutaneous T-Cell Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cutaneous T-Cell Lymphoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary Peripheral T-Cell Lymphomas (PTCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Peripheral T-Cell Lymphomas (PTCL). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

T-Cell Leukemia-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary T-Cell Leukemia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T-Cell Leukemia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

T-Cell Lymphomas-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary T-Cell Lymphomas- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T-Cell Lymphomas. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing dea...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Cutaneous T-Cell Lymphoma-API Insights, 2015,report provides Cutaneous T-Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Peripheral T-Cell Lymphomas (PTCL)-API Insights, 2015,report provides Peripheral T-Cell Lymphomas (PTCL) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF)...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Leukemia-API Insights, 2015,report provides T-Cell Leukemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Lymphomas-API Insights, 2015,report provides T-Cell Lymphomas drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00
$ 875.00
( Save 30% )

Read More

T-Cell Leukemia Global Clinical Trials Review, H2, 2016

30 Aug 2016  |  Published by:  GlobalData
Summary“T-Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top c...

$ 2,500.00

Read More

T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

30 Aug 2016  |  Published by:  GlobalData
Summary“T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Lymphomas. Report includes an overview of trial numbers and their average enrollment in to...

$ 2,500.00

Read More

Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016

30 Aug 2016  |  Published by:  GlobalData
Summary“Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral T-Cell Lymphomas (PTCL) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral T-Cell Lymphomas (PTCL). Report includes an overvi...

$ 2,500.00

Read More

Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016

29 Jun 2016  |  Published by:  GlobalData
SummaryGlobalData's clinical trial report, Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016 provides an overview of Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy clinical trials scenario. This report provides to...

$ 2,500.00

Read More

T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016

28 Jun 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Directs, T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016, provides in depth analysis on T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) targete...

$ 3,500.00

Read More

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016

31 May 2016  |  Published by:  GlobalData
Summary“Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous T-Cell Lymphoma. Report includes an overview of trial numbers and the...

$ 2,500.00

Read More

Tumor Necrosis Factor Receptor Superfamily Member 9 (T-Cell Antigen 4-1BB Homolog or T-Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H1 2016

18 May 2016  |  Published by:  Global Markets Direct
Summary‘Tumor Necrosis Factor Receptor Superfamily Member 9 (T-Cell Antigen 4-1BB Homolog or T-Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H1 2016’, provides in depth analysis on Tumor Necrosis Factor Receptor Superfamily Member 9 (T-Cell Antigen 4-1BB Homolog or T-Cell ...

$ 3,500.00

Read More
Total 30 records.